JP2024150466A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024150466A5 JP2024150466A5 JP2024103249A JP2024103249A JP2024150466A5 JP 2024150466 A5 JP2024150466 A5 JP 2024150466A5 JP 2024103249 A JP2024103249 A JP 2024103249A JP 2024103249 A JP2024103249 A JP 2024103249A JP 2024150466 A5 JP2024150466 A5 JP 2024150466A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025244399A JP2026048795A (ja) | 2020-05-18 | 2025-12-10 | Ｌｎｐ０２３の結晶形態 |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063026637P | 2020-05-18 | 2020-05-18 | |
| US63/026,637 | 2020-05-18 | ||
| US202063052699P | 2020-07-16 | 2020-07-16 | |
| US63/052,699 | 2020-07-16 | ||
| PCT/IB2021/054225 WO2021234544A1 (en) | 2020-05-18 | 2021-05-17 | Crystalline form of lnp023 |
| JP2022557633A JP7592743B2 (ja) | 2020-05-18 | 2021-05-17 | Ｌｎｐ０２３の結晶形態 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022557633A Division JP7592743B2 (ja) | 2020-05-18 | 2021-05-17 | Ｌｎｐ０２３の結晶形態 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025244399A Division JP2026048795A (ja) | 2020-05-18 | 2025-12-10 | Ｌｎｐ０２３の結晶形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024150466A JP2024150466A (ja) | 2024-10-23 |
| JP2024150466A5 true JP2024150466A5 (https=) | 2025-04-07 |
| JP7789850B2 JP7789850B2 (ja) | 2025-12-22 |
Family
ID=76076387
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022557633A Active JP7592743B2 (ja) | 2020-05-18 | 2021-05-17 | Ｌｎｐ０２３の結晶形態 |
| JP2024103249A Active JP7789850B2 (ja) | 2020-05-18 | 2024-06-26 | Ｌｎｐ０２３の結晶形態 |
| JP2025244399A Pending JP2026048795A (ja) | 2020-05-18 | 2025-12-10 | Ｌｎｐ０２３の結晶形態 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022557633A Active JP7592743B2 (ja) | 2020-05-18 | 2021-05-17 | Ｌｎｐ０２３の結晶形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025244399A Pending JP2026048795A (ja) | 2020-05-18 | 2025-12-10 | Ｌｎｐ０２３の結晶形態 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11603363B2 (https=) |
| EP (1) | EP4153580A1 (https=) |
| JP (3) | JP7592743B2 (https=) |
| KR (2) | KR20230009478A (https=) |
| CN (4) | CN120168469A (https=) |
| AU (2) | AU2021276912B2 (https=) |
| CA (1) | CA3180829A1 (https=) |
| IL (1) | IL297975A (https=) |
| TW (2) | TW202504893A (https=) |
| WO (1) | WO2021234544A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3675854T1 (sl) | 2017-08-31 | 2025-05-30 | Novartis Ag | Derivati piperidinil-indola za uporabo v zdravljenju glomerulopatije c3 |
| TW202504893A (zh) * | 2020-05-18 | 2025-02-01 | 瑞士商諾華公司 | Lnp023之結晶形式 |
| US11951101B2 (en) | 2020-07-16 | 2024-04-09 | Novartis Ag | Methods of using factor B inhibitors |
| WO2022143940A1 (zh) * | 2020-12-30 | 2022-07-07 | 南京明德新药研发有限公司 | 一系列哌啶取代的苯酸类化合物及其应用 |
| EP4333845A1 (en) * | 2021-05-07 | 2024-03-13 | Novartis AG | Iptacopan for the treatment of atypical hemolytic uremic syndrome |
| WO2022264101A1 (en) | 2021-06-18 | 2022-12-22 | Novartis Ag | Method of treating an autoimmune hematological disorder |
| CA3248808A1 (en) | 2022-03-04 | 2023-09-07 | Novartis Ag | USE OF IPTACOPAN FOR THE TREATMENT OF LUPUS NEPHROPATHY |
| JP7849520B2 (ja) * | 2022-06-30 | 2026-04-21 | 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司 | 含窒素架橋複素環誘導体の薬学的に許容される塩、結晶形及びその調製方法 |
| EP4669321A1 (en) | 2023-02-23 | 2025-12-31 | Novartis AG | METHODS OF USING FACTOR B INHIBITORS |
| CN121712505A (zh) | 2023-08-25 | 2026-03-20 | 诺华股份有限公司 | 使用因子b抑制剂的方法 |
| WO2025148628A1 (zh) * | 2024-01-10 | 2025-07-17 | 河北以岭医药研究院有限公司 | 哌啶基吲哚衍生物及其制备方法和应用 |
| WO2025172910A1 (en) | 2024-02-16 | 2025-08-21 | Novartis Ag | Factor b inhibitors for treatment of anca-associated vasculitis |
| WO2026003809A1 (en) * | 2024-06-29 | 2026-01-02 | Assia Chemical Industries Ltd. | Solid state forms of iptacopan hydrochloride |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0301259D0 (en) | 2003-01-20 | 2003-02-19 | Novartis Ag | Organic compounds |
| KR20130086534A (ko) | 2010-06-01 | 2013-08-02 | 플러스 케미칼스, 에스.에이. | 익사베필론의 고체 형태 |
| JO3425B1 (ar) | 2013-07-15 | 2019-10-20 | Novartis Ag | مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b |
| MX2018007392A (es) | 2015-12-23 | 2018-08-15 | Greenovation Biotech Gmbh | Polipeptidos para inhibir la activacion del complemento. |
| SI3675854T1 (sl) | 2017-08-31 | 2025-05-30 | Novartis Ag | Derivati piperidinil-indola za uporabo v zdravljenju glomerulopatije c3 |
| TW202504893A (zh) * | 2020-05-18 | 2025-02-01 | 瑞士商諾華公司 | Lnp023之結晶形式 |
-
2021
- 2021-05-17 TW TW113137576A patent/TW202504893A/zh unknown
- 2021-05-17 JP JP2022557633A patent/JP7592743B2/ja active Active
- 2021-05-17 KR KR1020227043301A patent/KR20230009478A/ko active Pending
- 2021-05-17 CN CN202510350702.0A patent/CN120168469A/zh active Pending
- 2021-05-17 TW TW110117696A patent/TWI858258B/zh active
- 2021-05-17 CN CN202180035091.0A patent/CN115667240B/zh active Active
- 2021-05-17 US US17/322,409 patent/US11603363B2/en active Active
- 2021-05-17 WO PCT/IB2021/054225 patent/WO2021234544A1/en not_active Ceased
- 2021-05-17 EP EP21727571.8A patent/EP4153580A1/en active Pending
- 2021-05-17 IL IL297975A patent/IL297975A/en unknown
- 2021-05-17 CN CN202510371145.0A patent/CN120208923A/zh active Pending
- 2021-05-17 KR KR1020257009662A patent/KR20250048392A/ko active Pending
- 2021-05-17 AU AU2021276912A patent/AU2021276912B2/en active Active
- 2021-05-17 CA CA3180829A patent/CA3180829A1/en active Pending
- 2021-05-17 CN CN202510349446.3A patent/CN120172955A/zh active Pending
-
2023
- 2023-02-14 US US18/168,711 patent/US12384758B2/en active Active
-
2024
- 2024-03-13 AU AU2024201640A patent/AU2024201640B2/en active Active
- 2024-06-26 JP JP2024103249A patent/JP7789850B2/ja active Active
-
2025
- 2025-05-13 US US19/206,665 patent/US20250270186A1/en active Pending
- 2025-12-10 JP JP2025244399A patent/JP2026048795A/ja active Pending